Search research articles
Contact Us
Filters
Showing results (11-20 of 685) with videos related to
Page
of 69
Sort By:
Annals of Surgical Oncology
|
September 21, 2010
ASBrS and ASO: a new partnership begins
Sheldon Feldman, Funda Meric-Bernstam
Current Breast Cancer Reports
|
March 4, 2014
Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer
Leila Green, Funda Meric-Bernstam
Annals of Translational Medicine
|
January 8, 2019
MK-2206 window of opportunity study in breast cancer
Argun Akcakanat, Funda Meric-Bernstam
Ebiomedicine
|
July 3, 2015
Whole Genome Sequencing in Cancer Clinics
Ken Chen, Funda Meric-Bernstam
Clinical Breast Cancer
|
November 10, 2005
Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy
Funda Meric-Bernstam, Francisco J Esteva
Seminars in Oncology
|
April 1, 2005
Mammalian target of rapamycin
Funda Meric-Bernstam, Gordon B Mills
Cold Spring Harbor Molecular Case Studies
|
December 8, 2017
Personalized cancer therapy-leveraging a knowledge base for clinical decision-making
Ecaterina Ileana Dumbrava, Funda Meric-Bernstam
Nature Reviews. Clinical Oncology
|
August 2, 2012
Overcoming implementation challenges of personalized cancer therapy
Funda Meric-Bernstam, Gordon B Mills
Annual Review of Medicine
|
September 27, 2023
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
Blessie Elizabeth Nelson, Funda Meric-Bernstam
Annals of Surgery
|
October 31, 2013
Reply to letter: "Waiting time for breast cancer treatment"
Jamie L Wagner, Funda Meric-Bernstam
Page
of 69
Search research articles
Search
Showing results (11-20 of 685) with videos related to
Sort By:
Page
of 69
Annals of Surgical Oncology
|
September 21, 2010
ASBrS and ASO: a new partnership begins
Sheldon Feldman, Funda Meric-Bernstam
Current Breast Cancer Reports
|
March 4, 2014
Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer
Leila Green, Funda Meric-Bernstam
Annals of Translational Medicine
|
January 8, 2019
MK-2206 window of opportunity study in breast cancer
Argun Akcakanat, Funda Meric-Bernstam
Ebiomedicine
|
July 3, 2015
Whole Genome Sequencing in Cancer Clinics
Ken Chen, Funda Meric-Bernstam
Clinical Breast Cancer
|
November 10, 2005
Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy
Funda Meric-Bernstam, Francisco J Esteva
Seminars in Oncology
|
April 1, 2005
Mammalian target of rapamycin
Funda Meric-Bernstam, Gordon B Mills
Cold Spring Harbor Molecular Case Studies
|
December 8, 2017
Personalized cancer therapy-leveraging a knowledge base for clinical decision-making
Ecaterina Ileana Dumbrava, Funda Meric-Bernstam
Nature Reviews. Clinical Oncology
|
August 2, 2012
Overcoming implementation challenges of personalized cancer therapy
Funda Meric-Bernstam, Gordon B Mills
Annual Review of Medicine
|
September 27, 2023
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
Blessie Elizabeth Nelson, Funda Meric-Bernstam
Annals of Surgery
|
October 31, 2013
Reply to letter: "Waiting time for breast cancer treatment"
Jamie L Wagner, Funda Meric-Bernstam
Page
of 69